🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Material Elimination

According to TikTok, the service has taken down problematic material and banned related hashtags and query recommendations. The organization said it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.

Within moments of entering one group, a seller posted contact information, where most transactions occur. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, health issues or past usage.

Product Information and Costs

Inside these groups, messages display black plastic parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.